Showing 2 posts of 2 posts found.


FDA approves new indication for MSD’s Zerbaxa

June 5, 2019
Research and Development Merck, Zerbaxa, bacterial infection, pharma

The FDA has approved US firm Merck’s Zerbaxa (ceftolozane and tazobactam) for adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial …


Cubist boosts antibiotics market presence

December 22, 2014
Sales and Marketing Antibiotics, Zerbaxa, antimicrobial resistance, bacteria, cubist, infections, infectious diseases

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …

Latest content